Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Mylan Defeats Teva's Motion for Summary Judgment on Copaxone; Court Orders Trial on Inequitable Conduct Defense to Commence July 11, 2011
MarketWatch
Saturday, June 18, 2011 - 11:09am
tags:
Mylan, Teva Pharmaceuticals, Copaxone, legal
China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity Read more: http://www.bradenton.com/2011/06/16/3280485/china-pharma-holdings-inc-states.html#ixzz1PdlaNG6T
Bradenton Herald, FL
Saturday, June 18, 2011 - 11:07am
tags:
China Pharma Holdings
K-V Pharmaceutical Shares Popped: What You Need to Know
Motley Fool
Saturday, June 18, 2011 - 11:05am
tags:
KV Pharmaceutical
Novartis To Offset Patent Cliff With Emerging Markets
Automated Trader
Saturday, June 18, 2011 - 11:02am
tags:
Novartis
SuperGen Stockholders Approve Stock Issuance In Connection with the Proposed Acquisition of Astex Therapeutics Limited
Centre Daily Times, PA
Saturday, June 18, 2011 - 10:56am
tags:
Supergen, Astex, M&A
AstraZeneca veteran Nicklasson named to Pozen’s board
MedCity News
Saturday, June 18, 2011 - 10:44am
tags:
AstraZeneca, Pozen
K-V Pharmaceutical Announces Divestiture of Generics Business to Zydus
Sacramento Bee, CA
Saturday, June 18, 2011 - 10:42am
tags:
KV Pharmaceutical, Zydus
TPI Discusses Non-Cash Non-Operational Financial Impact from Warrants
Sacramento Bee, CA
Saturday, June 18, 2011 - 10:41am
tags:
Tianyin Pharmaceutical
Johnson & Johnson Wins Second Trial Over Injury Claims Against Antibiotic
Bloomberg
Saturday, June 18, 2011 - 10:29am
tags:
JNJ, Levaquin, lawsuits
Novartis Vaccine for FDA Review
Yahoo/Zacks
Saturday, June 18, 2011 - 10:27am
tags:
Novartis, Menveo, meningitis
Abbott's Bardoxolone in Phase III
Yahoo/Zacks
Saturday, June 18, 2011 - 10:25am
tags:
diabetes, chronic kidney disease, Bardoxolone, Abbott Laboratories
Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of Risperdal Tablets and One Lot of Risperidone Tablets
Yahoo/PR NewsWire
Saturday, June 18, 2011 - 10:20am
tags:
Risperidone, Risperdal, Ortho-McNeil-Janssen, recalls
Cell Therapeutics, Inc. Reports Outcome of Special Meeting of Shareholders
Yahoo/PR NewsWire
Saturday, June 18, 2011 - 10:17am
tags:
Cell Therapeutics
5 Biotech Stocks With Insider Buying and Undervalued by Analysts' EPS
Seeking Alpha
Saturday, June 18, 2011 - 10:15am
tags:
Complete Genomics, QLT Inc, Regeneron, Theravance, Ziopharm
SEC settles $1.2M Martek insider trading case
bizjournals.com
Saturday, June 18, 2011 - 10:06am
tags:
Martek, legal
Titan Pharmaceuticals Provides Additional Details on Confirmatory Phase 3 Study of Probuphine
Yahoo/MarketWire
Saturday, June 18, 2011 - 10:05am
tags:
Titan, Probuphine, addiction
Curis: Next Week's Data Release Could Bring Volatility to Shares
Seeking Alpha
Saturday, June 18, 2011 - 10:02am
tags:
Curis, basal cell carcinoma, hedgehog pathway inhibitor
Phase II Data Evaluating Clinical Benefit of Revlimid Plus Rituximab for Patients with Untreated Indolent B-Cell Lymphomas Presented at International Conference on Malignant Lymphoma
Yahoo/BusinessWire
Saturday, June 18, 2011 - 10:00am
tags:
Revlimid, lymphoma, rituximab
Piper Jaffary Director Bullish On Pacific Biosciences (PACB), Fluidigm (FLDM) And Complete Genomics (GNOM): Discover All His Top-rated Medical Stocks In An Exclusive Interview
Yahoo/Wall Street Transcript
Saturday, June 18, 2011 - 9:58am
tags:
Pacific Biosciences, Complete Genomics
Cubist might stay clear of Ph3 for antibiotic, analyst says
Fierce Biotech
Friday, June 17, 2011 - 12:39pm
tags:
antibiotics, Cubist Pharmaceuticals, Clostridium Difficile

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.